v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Sep. 30, 2025
Sep. 30, 2024
Operating activities            
Net loss $ (16,795,000) $ (8,272,000) $ (32,773,000) $ (30,402,000) $ (46,131,000) $ (20,034,000)
Adjustments to reconcile net loss to net cash used in operating activities:            
Depreciation 42,000 60,000 129,000 306,000 366,000 472,000
Amortization of intangible assets 395,000 407,000 1,195,000 1,285,000 1,692,000 1,543,000
Impairment of long-lived assets 725,000 725,000 725,000 1,333,000
Issuance of warrants in connection with financing activities, charged to expense         6,458,000 1,023,000
Issuance of warrants to placement agent     280,000    
Issuance of common stock for amendment of RaGE earnout     1,121,000    
Change in fair value of earnout liability (210,000) (960,000) (490,000) (440,000) (31,879,000)
Change in fair value of warrants (108,000) (612,000) 320,000 (1,237,000) (804,000) (1,415,000)
Change in fair value of PIPE make-whole liability         (830,000)
Merger-related transaction costs expensed         4,009,000
Private placement costs expensed         280,000 2,894,000
Change in fair value of notes payable 27,000 27,000    
Loss on extinguishment of notes payable 3,791,000 17,000 4,218,000 300,000    
Loss on issuance of preferred shares and liability-classified warrants 3,707,000 3,707,000    
Noncash private placement costs expensed     514,000    
Noncash financing costs expensed 600,000 443,000 600,000 443,000 7,266,000 2,894,000
Stock-based compensation 2,350,000 7,102,000 9,941,000 20,256,000 25,619,000 21,383,000
Deferred income taxes     (22,000) (15,000) 1,000 (2,432,000)
Loss on disposal of assets     472,000    
Other non-cash items     (389,000) (508,000) 751,000 693,000
Changes in operating assets and liabilities:            
Accounts receivable     588,000 1,331,000 1,430,000 (1,817,000)
Inventory     (27,000) 479,000 290,000 (105,000)
Prepaid expenses and other assets     (1,100,000) (104,000) 11,000 60,000
Accounts payable     (2,835,000) 376,000 (1,283,000) 3,862,000
Accrued expenses and other current liabilities     1,027,000 903,000 922,000 2,852,000
Net cash used in operating activities     (14,719,000) (5,600,000) (10,113,000) (18,388,000)
Investing activities            
Proceeds from sale of property and equipment     27,000 27,000
Acquisition of property and equipment     (9,000) (16,000) (26,000) (44,000)
Acquisitions of businesses, net of cash acquired         (1,064,000)
Net cash provided by (used in) investing activities     (9,000) 11,000 1,000 (1,108,000)
Financing activities            
Proceeds from sale of common stock and warrants in private placements     3,645,000 3,645,000 3,585,000
Proceeds from issuance of common stock     1,254,000 600,000 1,600,000 3,529,000
Proceeds from issuance of preferred shares and liability-classified warrants     1,975,000    
Proceeds from exercise of stock options     55,000 225,000
Proceeds from issuance of common stock in public offering     5,360,000    
Proceeds from exercise of warrants     17,000 4,520,000 4,000
Proceeds from issuance of notes payable     8,649,000 2,575,000    
Principal payments on notes payable     (2,842,000) (655,000) (1,215,000) (1,749,000)
Principal payments on notes payable – related parties     (854,000) (445,000) (574,000) (1,463,000)
Deferred consideration paid for acquisition of business     (174,000) (174,000) (174,000)
Proceeds from the Merger and PIPE         21,014,000
Merger-related transaction costs paid         (6,946,000)
Net cash provided by financing activities     13,597,000 5,563,000 13,119,000 19,673,000
Net increase (decrease) in cash     (1,131,000) (26,000) 3,007,000 177,000
Cash, beginning of period     3,273,000 266,000 266,000 89,000
Cash, end of period $ 2,142,000 $ 240,000 2,142,000 240,000 3,273,000 266,000
Supplemental cash flow information            
Cash paid for interest     1,706,000 757,000 1,814,000 521,000
Cash paid for income taxes    
Non-cash investing and financing activities:            
Settlement of notes payable and other liabilities in common stock     $ 10,561,000 $ 1,361,000 1,379,000
Class A Common Stock issued for RaGE earnout         1,808,000
Unpaid Merger-related transaction costs         1,423,000
Contingently redeemable convertible stock issued for acquisition of EMI Solutions, Inc.         8,856,000
Class A Common Stock issued for acquisition of RaGE Systems, Inc.         7,682,000
Deferred purchase consideration for acquisitions of businesses         3,522,000
Conversion of SAFEs to common stock         1,522,000
Deemed dividend from warrant price adjustment         661,000
Issuance of warrants in connection with notes payable, recorded as debt discount         183,000
Nonrelated Party [Member]            
Financing activities            
Proceeds from issuance of notes payable         5,317,000 1,198,000
Related Party [Member]            
Financing activities            
Proceeds from issuance of notes payable         450,000
Principal payments on notes payable         $ (330,000) $ (165,000)